X

pharmaceuticals

Lupin Ltd (LUPIN) Q2 FY23 Earnings Concall Transcript

Lupin Ltd (NSE:LUPIN) Q2 FY23 Earnings Concall dated Nov. 10, 2022 Corporate Participants: Vinita Gupta -- Chief Executive Officer Ramesh…

Cipla Limited Q2 FY23 Earnings Conference Call Insights

Key highlights from Cipla Limited (CIPLA) Q2 FY23 Earnings Concall Management Update: [00:02:21] CIPLA reported the highest quarterly revenue historically…

Solara Active Pharma Sciences Limited (SOLARA) Q2 FY23 Earnings Concall Transcript

Solara Active Pharma Sciences Limited  (NSE:SOLARA) Q2 FY23 Earnings Concall dated Nov. 09, 2022 Corporate Participants: Abhishek Singhal -- Investor Relations Jithesh…

Sequent Scientific Limited (SEQUENT) Q2 FY23 Earnings Concall Transcript

Sequent Scientific Limited (NSE:SEQUENT) Q2 FY23 Earnings Concall dated Nov. 08, 2022 Corporate Participants: Abhishek Singhal -- Head of Investor…

Divi’s Laboratories Ltd Q2 FY23 Earnings Conference Call Insights

https://youtu.be/e1-tljnhSVM Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q2 FY23 Earnings Concall Management Update: [00:06:48] DIVISLAB stated that though global…

Rossari Biotech Ltd (ROSSARI) Q2 FY23 Earnings Concall Transcript

Rossari Biotech Ltd (NSE:ROSSARI) Q2 FY23 Earnings Concall dated Nov. 07, 2022 Corporate Participants: Anoop Poojari -- Client Manager Edward…

Limited (POLYMED) Q2 FY23 Earnings Concall Transcript

Poly Medicure Limited (NSE:POLYMED) Q2 FY23 Earnings Concall dated Nov. 07, 2022 Corporate Participants: Himanshu Baid -- Managing Director Naresh…

Sun Pharmaceutical Industries Limited Q2 FY23 Earnings Conference Call Insights

Key highlights from Sun Pharmaceutical Industries Limited (SUNPHARMA) Q2 FY23 Earnings Concall Q&A Highlights: [00:16:46] Tushar Manudhane of Motilal Oswal…

Sun Pharmaceutical Industries Limited (SUNPHARMA) Q2 FY23 Earnings Concall Transcript

Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Q2 FY23 Earnings Concall dated Nov. 01, 2022  Corporate Participants: Nimish Desai -- Investor Relations…

Dr. Reddy’s Laboratories Limited Q2FY23; Net Profit Increased By 12%

Dr. Reddy's Laboratories Limited (NSE: DRREDDY) reported Revenue from Operations for Q2 FY23 of ₹63,318 Crore up from ₹57,896 Crore…